Introduction 55
The risk of hip fractures in those with Type 1 diabetes mellitus (T1DM) is reported to be 56 7-12 times greater (1, 2) and this increased risk is also evident in young adults (3). The 57 process of differentiation of mesenchymal stem cells into either adipocytes or osteoblasts 58 is regulated by a number of growth factors including insulin, oxygen tension and blood 59 flow within the bone marrow (4, 5). T1DM is also associated with abnormalities of the 60 growth hormone (GH)/insulin-like growth factor type 1 (IGF-1) axis with biochemical 61 evidence of GH resistance (6). Growth hormone (GH) and IGF-1 also are important 62 regulators of bone homeostasis and important for the maintenance of bone mass (7) and 63 may also influence body composition and bone marrow adiposity (8). Mouse models of 64 T1DM exhibit increased bone marrow adiposity (BMA), increased adipocyte markers and 65 increased numbers of lipid-dense adipocytes in the bone marrow (9). Childhood and 66 adolescence are critical periods for skeletal development (10) and it is possible that those 67 affected by T1DM at these ages may be especially susceptible. 68 69 On dual energy X-Ray absorptiometry (DXA), adults with T1DM do show a reduction in 70 bone mineral density (BMD) Z-score, reported in a meta-analysis at -0.22 at the lumbar 71 spine and -0.37 at the hip (11), but their fracture risk is much higher (1-3,11) than 72 expected for this modest reduction in BMD. Recent advances in magnetic resonance 73 (MR) imaging have led to the generation of high resolution 3D images of bone structure 74 that correlate with other techniques such as computed tomography (12,13). In addition, 75 MR can quantify the amount of intra-abdominal fat, and MR spectroscopy can also 76 estimate the fat that is present within the bone marrow (14). There is, therefore, the 77 potential to combine these MR-based techniques to obtain objective data on bone 78 microarchitecture and fat content and study these in a condition such as T1DM. 79
80
With the increased reports of an association between marrow adiposity and bone health 81 (15), the current study was designed to improve the understanding of the bone pathology 82 in adults with childhood-onset T1DM by using high resolution MRI and biochemical 83 markers of GH action and bone turnover. To reduce the confounding effect of sex 84 hormones, this study targeted young women with T1DM and compared them to a group 85 of age-matched healthy women. 86
Research Design & Methods 108
Subjects 109
Between July 2012 and July 2013, 61 eligible women between the ages of 20 and 30 110 years and who were diagnosed before the age of 16 years were approached at one hospital 111 clinic and from this group, 30 volunteered to participate. In addition, 28 age-matched 112 healthy control women working at the local university and hospital were also recruited. 113
Exclusion criteria included the presence of metallic implants and pacemakers, active or 114 planned pregnancy or lactation, kidney disease, chronic use of drugs that are known to 115 affect bone health and other chronic diseases that are known to be associated with an 116 increased risk of fractures. Information on personal health and lifestyle habits, including 117 cigarette smoking, alcohol consumption, current medication, use of vitamins or calcium, 118 age at menarche, use of oral contraceptives, hours of weight-bearing physical activity per 119 week, history of fractures and a family history of early osteoporosis was also collected. 120
Information on age of diagnosis, disease duration, insulin therapy and presence of 121 microvascular complications was obtained from the case records. A glycosylated 122 hemoglobin (HbA1c) measurement within a two-week period of the scan visit was used 123 as current HbA1c. The study protocol was approved by the national research ethics 124 service and all participants provided written informed consent. 125
126

Biochemical Markers of Bone Metabolism, Adiposity & GH/IGF-1 Axis 127
In 25 cases and 24 control participants, non-fasting blood samples were collected, 128 centrifuged and the supernatant stored at -80 0 C. Sample collection was standardised with 129 collection performed in the afternoon to coincide with the clinic visit. Plasma total 130 6 terminal telopeptide of Type I collagen (CTX) was measured by ELISA to assess bone 135 resorption (Immunodiagnostic systems, Boldon, Tyne and Wear, United Kingdom). The 136 intra-assay variation for OC, uOC, BAP and CTX was 5.3%, 13.2%, 0.8% and 3.8%, 137 respectively. Plasma leptin, IGF-I and its binding proteins, IGFBP3, and the acid labile 138 subunit (ALS) were also determined, using ELISA (Mediagnost GmbH, Reutlingen, 139 Germany). Intra-assay variabilities were 6.1%, 0.6%, 4.1% and 3.4%, respectively. 25-140
Hydroxy vitamin D (25OHD) concentration was measured by a radioimmunoassay 141 (Immunodiagnostic Systems, Boldon, UK). 142 143
Micro-MRI 144
MRI images of the proximal tibia with a resolution of 0.3mm x 0.3mm x 0.3mm were 145 acquired with a 3T MRI scanner (Siemens Verio, Erlangen Germany) using a 146 transmit/receive extremity coil which was suitable for knee imaging. The method used 147 has been described previously (16) but briefly, the images were acquired from the right 148 proximal tibia using the epiphyseal growth plate as a reference, with the first slice 149 positioned immediately distal to the growth plate and subsequent slices positioned distally 150 along the tibia. Standardized analysis was performed using the slice that was located at 151 the insertion point of the patellar ligament. The images (Fig.1) were coded and analysed 152 blindly using software written in IDL (Research Systems Inc, Boulder, CO) to obtain 153 measures for apparent bone volume to total volume ratio (appBV/TV), apparent 154 trabecular number (appTbN), apparent trabecular thickness (appTbTh) and apparent 155 trabecular spacing (appTbSp). The analysis for each subject was repeated 4 times and 156 averaged. In 29 out of 30 cases and in 27 out of 28 control participants, the images were 157 of a sufficiently good quality to be analysed. Validation of the software was performed 158 using a custom-made phantom, which consisted of a cylinder containing two discs with a 159 parallel arrangement of nylon strings -0·4-mm diameter string was used in one disc and7 with different spacings in each -0·5, 1·0 and 1·5 mm. The phantom was filled with a 162 NiSO 4 solution to ensure adequate signal surrounding the strings, in a similar way to soft 163 tissue surrounding bone. Due to partial volume effects and the similar magnitude of the 164 resolution of the micro-MRI sequence to the thickness of the strings, the exact thickness 165 of the strings could not be measured, and hence, the calculated bone parameters were 166 expressed as 'apparent' values. The phantom validation allowed an optimal assessment of 167 the effect of string thickness and string spacing on the apparent values. An assessment of 168 repeatability was performed by one operator who independently analysed ten datasets 169 four times each. 170
171
MRS 172
1H-MRS was performed using a 6-channel body array (anterior) and a 12-channel spine 173 coil (posterior). Spectra were obtained from a 20mm x 20mm x 20mm volume within the 174 vertebral body of L3, using a method which has been described previously (16). Analysis 175 was performed following fitting of the spectrum in the time domain using a nonlinear 176 least-squares algorithm, AMARES (17) in the Java-based magnetic resonance user 177 interface (jMRUI) software package (18) . The area under the water peak and lipid peak 178 (Fig.2) 
MRI of abdominal fat 184
Of the participants who had MRS scans, in 24 cases and 19 controls, approval was also 185 obtained to assess abdominal fat during the same scanning session using the 6-channel 186 body array and the 12-channel spine coil. A T1 weighted turbo-spin-echo sequence was 187 
Results
211
Clinical Characteristics 212
There were no significant demographic or anthropometric differences between the cases 213 and controls (Table 1) . Notably, the median BMI in the cases and controls was 24.8kg/m 9 (18.2, 31.2) and 22.9kg/m 2 (18.3, 33.9), respectively (p=0.1) with similar amounts of 215 physical activity reported in the cases and controls. Of the 30 cases and 28 controls, 9 216 (30%) and 3 (11%) reported a history of traumatic fractures (p=0.07). In 2 cases, the 217 fractures had occurred before the onset of diabetes and in the other 7 cases, the duration 218 of diabetes at the time of the fracture ranged between 2.5yrs and 16yrs. The median 219 duration of T1DM was 12.8yrs (7.9, 34.2) with a median age at diagnosis of 9.9yrs (0.5, 220 15.0). Of the 30 cases, 7 were on twice-daily insulin injections, 6 were on three-daily 221 injections and 17 were on four-daily injections. The median total daily insulin dose for 222 body weight was 0.94 IU/kg/d (0.43, 1.52) and the median current HbA1C was 9.8% (5, 223 16) equivalent to 84mmol/mol (31, 151). Of the 30 cases, 15 (50%) had retinopathy of 224 which 12 had background retinopathy alone, 2 (7%) were being treated for hypertension, 225 1 (3%) had neuropathy and gastroparesis and none had microalbuminuria. One of the 226 cases had stable Crohn's disease requiring sulfasalazine therapy only for two years prior 227 to the study and two cases were on a stable dose of thyroxine for acquired 228 hypothyroidism, one of three years duration and another of five years duration. 229
230
Biochemical Markers of Bone Metabolism, Adiposity & GH/IGF-1 Axis 231
Amongst the markers of bone metabolism, plasma 25OHD and CTX were significantly 232 lower in cases compared to controls (Table 1) . However, serum PTH and markers of bone 233 formation were similar in both groups (Table 1) . Amongst the markers of the GH/IGF-1 234 axis, plasma IGF-1 and ALS were significantly lower in the cases compared to controls 235 whilst IGFBP3 was similar in both groups (Table 1) . Plasma leptin was similar in the two 236 groups and, as expected, showed a positive association to BMI (r,0.33; p=0.02) ( Table 1) . 237
Despite no significant differences in the BMI and plasma leptin between cases and 242 controls, abdominal adiposity including CSA, VAT and TAT, was significantly higher in 243 cases compared to controls (Table 2) were significantly lower and appTbSp significantly higher in cases compared to controls 252 (Table 2) . AppBV/TV and appTbN did not show any association to any biochemical 253 markers or MRI-based markers of abdominal obesity. However, appTbSp showed a 254 significant inverse association to serum ALS (r=-0.30, p=0.04) and OC (r=-0.38, p=0.009) 255 (Fig.3) . This inverse association was not observed between appTbSp and uOC. An 256 inverse association was also suggested between appTbSp and serum IGF-1 but this did 257 not reach statistical significance (r=-0.27, p=0.06). In the T1DM cases, there was no 258 association of appBV/TV, appTbN or app TbSp with HbA1c, age at diagnosis, duration of 259 T1DM or daily insulin dose corrected for weight. However, there was a clear difference in 260 median appBV/TV between those cases who had retinopathy and who did not have 261 retinopathy. The median appBV/TV was 0.285 (0.22, 0.33) in those cases with 262 retinopathy compared to 0.33 (0.25, 0.37) in those cases without retinopathy (p=0.02) 263 (Fig.4) . The HbA1c was 9.5% (5, 16) and 9.2% (5.5, 13) in the cases with and without 264 retinopathy (NS). 265
Median vertebral BMA, expressed as percentage fat fraction (%FF), was higher in cases 268 than controls but this did not reach statistical significant difference (Table 2) . Vertebral 269 BMA tended to show a positive association to VAT (r=0.3, p=0.051) which, as stated 270 earlier, was higher in cases compared to controls (Table 2 ). There was no association 271 between vertebral BMA and markers of GH/IGF-1 axis or bone turnover. Median BMA 272 was 30.5% (9.9, 59.9) in those cases with retinopathy compared to 31.6% (11.3, 50.1) in 273 those cases without retinopathy (p=0.97). The current study was primarily aimed at using MRI to compare the trabecular 296 microarchitecture in young women with childhood-onset T1DM with that in healthy age-297 matched women and is the first published clinical study to clearly show that this is altered 298 in the former with reduced bone volume and trabecular number and increased trabecular 299 separation. In addition, the study has also provided some insights into the underlying 300 mechanisms that may lead to abnormality of skeletal development in adults with T1DM. 301
302
In keeping with other reports of a higher prevalence of vitamin D deficiency in young 303 people with T1DM, the women who participated in this study had lower vitamin D levels 304 than the control group (21, 22). However, these levels were not particularly low and were 305 not associated with a raised PTH or any other marker of bone formation or bone 306 microarchitecture and it is, therefore, unclear whether the the lower vitamin D levels had 307 a particularly marked contributory role. It is also unlikely that the women with T1DM had 308 any other underlying genetic bone disorder as none had been revealed on history and 309 examination. The reported rate of fractures in these cases seemed higher but not 310 significantly different to controls and within the expected frequency for self-reported 311 fractures in healthy women (23). 312
313
The findings in the current study suggest that the deficits in bone microarchitecture that 314 were encountered in T1DM may have a multifactorial aetiology. Firstly, the negative 315 association between total osteocalcin, a marker of bone formation and trabecular 316 separation in the study participants suggests that the osteopathy in T1DM may be linked 317 to reduced bone formation rather than increased bone resorption. This was further 318 reinforced by the lower levels of CTX, a marker of bone resorption, in the T1DM cases. 319
This state of low bone turnover with reduced bone formation in T1DM has been reported 320 previously (24, 25) and has been known to be associated with GH deficiency (26). To13 facilitate recruitment, the current study did not stipulate fasting blood samples. Markers of 322 bone turnover, and specially markers of bone resorption, such as CTX, show a diurnal 323 variation and may be affected by fasting status (27) and future studies would benefit from 324 standardisation of sample collection. 325
326
The women with T1DM also had lower levels of circulating IGF-1 and ALS and the 327 negative association of trabecular separation with ALS raises the possibility that the 328 GH/IGF-1 axis and, in particular, reduced GH activity, may contribute to the altered bone 329 microarchitecture. GH and IGF-1 are important regulators of bone homeostasis and 330 important for the maintenance of bone mass (7). GH stimulates osteoblastic proliferation 331 through stimulation of circulating and local IGF-1 and it inhibits adipogenesis (28). In 332 humans, systemic availability of active IGF-1 is modulated through its binding to proteins The women with T1DM in this study did not have a significantly higher BMI compared 358 to controls but they had markedly higher visceral adiposity and it is possible that this 359 abnormality is also associated with functional GH deficiency (38). Although bone marrow 360 adiposity was similar in the cases and controls, the cases did have increased trabecular 361 spacing which showed an inverse relationship to circulating ALS and osteocalcin. 362
Increased trabecular spacing is not universally associated with increased bone marrow 363 adiposity (15); whereas this association may be encountered in GH deficiency (16, 39), in 364 other conditions such as osteogenesis imperfecta, the two parameters do not show an 365 association (16). It is also possible that in states of GH resistance such as T1DM, bone 366 marrow adiposity may be increased. The current study was not powered to detect 367 significant differences in bone marrow adiposity between the cases and controls and it is 368 possible that with a larger sample size this would also have been detected. The finding of 369 an abnormality of bone microarchitecture and bone marrow adiposity would be consistent 370 with a defect in bone marrow mesenchymal stem cell differentiation which leads to a net 371 reduction in bone formation in favour of adipogenesis (40) and as previously described in 372 streptozocin induced T1DM mice (41) as well as conditions that are associated with 373 relative IGF-1 deficiency (8, 42, 43) . 374 Finally, the current study highlights the objective versatility of MRI based techniques in 375 identifying differences in relatively small cohorts. Although there is now sufficient 376 supporting evidence for the use of MRI for assessing bone microarchitecture (44), with 377 the greater availability of 3T MRI scanners, there is a need to standardise the analytical 378 techniques so that the clinical utility of MRI in metabolic conditions that are associated 379 with abnormalities of bone health can be realised. With technological advances in 380 hardware as well as analytical tools, an improvement in the current limited resolution of 381 MRI as well as its ability to study cortical structure is highly likely. We chose to study 382 young women only, primarily because they are more likely to develop osteoporosis in the 383 long-term and to avoid the confounding effects of sex hormones but given that the 384 increased fracture incidence has been encountered in both sexes and bone marrow 385 adiposity increases with old age (45, 46), there is a need to study older as well as younger 386 people with diabetes in both sexes. We did not perform DXA in this group but there is a 387 need in future studies to assess the relationship of microMRI findings to DXA BMD as 388 well as DXA based methods of assessing trabecular architecture (47). Given that hip 389 fractures are reported to be commoner in people with T1DM (1,2,11), there is a place to 390 examine the microarchitecture at this site too. The women with T1DM in this current 391 group had a relatively high HbA1c and as expected for a population sample from an inner 392 city area in the west of Scotland (48). A relationship between HbA1c and the bone 393 parameters was not observed in the current study and perhaps this investigation would 394 have been facilitated if there was a wider range of HbA1c. The lack of a relationship of 395 the bone findings with HbA1c also raises the need to investigate the association with 396 additional markers of glycation such as pentosidine (49). The lack of a sufficient number 397 of cases with other complications associated with microvasculopathy limited the 398 investigation of this association in the current study. The relationship between bone 399 pathology and Type 2 DM is less clear with a lower risk of fractures (3). However, a 400 recent study that examined bone marrow adiposity in women with Type 2 DM did report 401 a higher level of vertebral bone marrow adiposity in those who had a history of a fracture 402 1"
